The role of cytokines in sickle cell disease

Annals of Hematology

Volumn 79, Issue 8, 2000, Pages 407-413

  Makis, A C ^a,b   Hatzimichael, E C ^a,b   Bourantas, K L ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Department of Hematology ^*  (Greece)

Author keywords

Cytokines; Sickle cell disease

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL OCCLUSION; CYTOKINE PRODUCTION; ERYTHROCYTE; HEMATOPOIESIS; HEMOLYSIS; IMMUNOPATHOLOGY; LEUKOCYTE ADHERENCE; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

CYTOKINES; HUMANS; SICKLE CELL TRAIT;

EID: 0033869596     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000173     Document Type: Review

References (94)

1. Francis RB, Johnson CS (1991) Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood 77:1405-1414
2. Platt OS, Thorington B, Brambilla DJ, Milner PF, Rosse WF (1993) Pain in sickle cell disease: rates and risk factors. N Engl J Med 325:11-16
3. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639-1644
4. Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J (1992) Subclinical ischemic episodes during the steady state of sickle cell anaemia. J Clin Pathol 45:902-906
5. Steiberg MH, Hebbel RP (1983) Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity. Am J Hematol: 405-416
6. Mozzarrelli A, Hofrichter J, Eaton WA (1987) Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 237:500-506
7. Hebbel RP (1997) Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 99:2561-2564
8. Hebbel RP, Boogaerts MAB, Eaton JW, Steinberg MH (1980) Erythrocyte adherence to endothelium in sickle cell anemia: a possible determinant of disease severity. N Engl J Med 302:992-995
9. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M (1987) Endothelial cells interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152-157
10. Fabry ME, Kaul DK. Sickle cell vaso-occlusion (1991) Hematol Oncol Clin North Am 5:375-398
11. Kaul DK, Fabry ME, Costantini F, Rubin M, Nagel RL (1995) In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96:2845-2853
12. Mohandas N, Evans E (1984) Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood 64:282-287
13. 1 glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:3548-3555
14. Kasschau MR, Barabino GA, Bridges KR, Golan DE (1993) Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 87:771-780
15. Kumar A, Eckmam JR, Swerlick RA, Wick TM (1996) Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin. Blood 88:4348-4358
16. Swerlick RA, Eckman JR, Kumar A, Jeitler M, Wick TM (1993) Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:1891-1899
17. Gee BE, Platt OS (1995) Sickle reticulocytes adhere to V-CAM-1. Blood 85:268-274
18. Tissot Van Patot MC, MacKenzie S, Tucker A, Voelkel NF (1996) Endotoxin-induced adhesion of red blood cells to pulmonary artery endothelial cells. Am J Physiol 270:28-36
19. Vordermeier S, Singh S, Biggerstaff J, Harrison P, Grech H, Pearson TC, Dumonde DC, Brown KA (1992) Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF). Br J Hematol 81:591-597
20. Natarajan M, Udden MM, McIntire LV (1996) Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro. Blood 87:4845-4852
21. Sowemimo-Coker S, Haywood LJ, Meiselman HJ, Francis RB Jr (1989) Interleukin-1 increases adherence of normal and sickle erythrocytes to endothelial cells (abstract). Blood 74[suppl]:313a
22. Schroder JM, Christophers E (1989) Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 142:244-251
23. Luster AD (1998) Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
24. Hagiwara T, Suzuki H, Kono I, Kashiwagi H, Akiyama Y, Onozaki K (1998) Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. Am J Pathol 136:39-47
25. Osborn L, Hession C, Tizard R, Vassalo C, Luhowsky JS, Chi-Rosso G, Lobb R (1989) Direct cloning of vascular cell adhesion molecule-1, a cytokine induced endothelial protein that hinds to lymphocytes. Cell 59:1203-1211
26. Sugihara K, Sugihara T, Mohandas N, Hebbel RP (1992) Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80:2634-2642
27. Britlain HA, Eckman JR, Swerlick RA, Howard R, Wick TM (1993) Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81:2137-2143
28. Lawler J (1986) The structural and functional properties of thrombospondin. Blood 67:1197-1209
29. Asch AS, Tepler J, Sibiger S, Nachman RI (1991) Cellular attachment to thrombospondin. Cooperative interactions between receptors systems. J Biol Chem 266:1740-1745
30. Kaul DK, Nagel RL, Chen D, Tsai HM (1993) Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion. Blood 81:2429-2438
31. Wick TM, Eckman JR (1996) Molecular basis of sickle cell-endothelial cell interactions. Curr Opin Hematol 3:118-124
32. Duits AJ, Pieters RC, Saleh AW, van Rosmalen E, Katerberg H, Berend K, Rojer RA (1996) Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol 81:96-98
33. Saleh AW, Duits AJ, Gerbers A, de Vries C, Hillen HF (1998) Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy. Acta Hematol 100:26-31
34. Malave I, Perdomo Y, Escalona E, Rodriguez E, Anchustegui M, Malave H, Arends T (1993) Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease. Acta Hematol 90:172-176
35. Kuvibidila S, Gardner R, Ode D, Yu L, Lane G, Warner RP (1997) Tumor necrosis factor alpha in children with sickle cell disease in stable condition. J Natl Med Assoc 89:609-615
36. Francis RB Jr, Haywood LJ (1992) Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 84:611-615
37. Bourantas KL, Dalekos GN, Makis A, Chaidos A, Tsiara S, Mavrides A (1998) Cytokines and acute-phase proteins during the steady state of sickle cell disease. Eur J Hematol 61:49-54
38. Solovey A, Lin Y, Brown P, Choong S, Wayner E, Hebbel RP (1997) Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590
39. Hedo CC, Akinola YA, Okpala IE, Durojaiye AO, Salimonu LS (1993) Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med 233:467-470
40. Singhal A, Doherty JF, Raynes JG, McAdam KP, Thomas PW, Serjeant BE, Serjeant GR (1993) Is there an acute-phase response in steady-state sickle cell disease? Lancet 341:651-653
41. Monnet D, Diallo I, Sangare A, Yapo AE (1993) Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease. Bull Soc Pathol Exot 86:282-285
42. Moore C, Ehlayel M, Inostroza J, Leiva LE, Kuvibidila S, Yu L, Gardner R, Ode' DL, Warrier R, Sorensen RU (1998) Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease. J Natl Med Assoc 90:157-163
43. Klug PP, Kay N, Jensen WN (1982) Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 8:175-184
44. Nawroyh PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1. J Exp Med 163:1363-1367
45. Mantovani A, Sozzani A, Vecchi A, Introna M, Allvena P (1997) Cytokine activation of endothelial cells: new molecules for an old paradigm. Thromb Hemost 78:406-414
46. Loppnow H, Bil R, Hirt S, Sconbeck U, Herzberg M, Werdan K, Rietschel ET, Brandi E, Flad HD (1998) Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91:134-139
47. Su SB, Mukaida N, Matsushima K (1996) Rapid secretion of intracellular pre-stored interleukin-8 from rabbit platelets upon activation. J Leukoc Biol 59:420-426
48. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15:74-80
49. Dinarello CA (1997) Role of pro-and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J Biol Regul Homeost Agents 11:91-103
50. Styles LA, Lubin B, Vichinsky E, Lawrence M, Hua M, Test S, Kuypers F (1997) Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 89:2544-2559
51. Hofstra TC, Kalra VK, Meiselman HJ, Coates TD (1996) Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood 87:4440-4447
52. Lard LR, Mul FP, de Haas M, Roos D, Duits AJ (1999). Neutrophil activation in sickle cell disease. J Leukoc Biol 66:411-415
53. Fadlon E, Vordermeier S, Pearson TC, Mire-Sluis AR, Dumonde DC, Phillips J, Fishlock K, Alun Brown K (1998) Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 91:266-274
54. Duits AJ, Schnog JB, Lard LR, Saleh AW, Rojer RA (1998). Elevated IL-8 levels during sickle cell crisis. Eur J Haematol 61:302-305
55. Francis RB Jr (1989) Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Hemostasis 19:105-111
56. Wun T (1998) Platelet activation in patients with sickle cell disease. Br J Hematol 100:741-744
57. Rothman SM, Fulling KH, Nelson JS (1986) Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 20:684-690
58. Libby P, Warner SjC, Friedmann GB (1988) Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81:487-498
59. Rubycki AC, Musto S, Swinson GL, Benjamin LJ, Nagel RL, Schwartz RS (1991) Increased levels of endothelin-1 in plasma of sickle cell anemia patients (abstract). Blood 78:202a
60. Longenecker G, Culbertson D, Beyers E, Manci E, Mankad V (1991) Plasma endothelin (ET) levels are elevated in sickle cell disease (SCD) (abstract). Blood 78:1645a
61. Hammerman SI, Kourembanas S, Conca TJ, Tucci M, Brauer M, Farber HW (1997) Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 156:280-285
62. Werdehoff SG, Moore RB, Hoff CJ, Fillingim E, Hackman AM (1998) Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. Am J Hematol 58:195-199
63. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA (1998) Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 92:2551-2555
64. Levin ER (1995) Endothelins. N Engl J Med 333:356-363
65. Phelan M, Perrine SP, Brauer M, Faller DV (1995) Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest 96:1145-1151
66. Kahaleh MB, Fan S (1997) Effects of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 15:163-167
67. Kruse-Elliott KT, Whorton AR, Olson NC (1998) Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. Shock 9:40-45
68. Kanse SM, Takahashi K, Lam HC, Rees A, Warren JB, Porta M, Molinatti P, Ghatei M, Bloom SR (1991) Cytokine stimulated endothelin release from endothelial cells. Life Sci 48:1379-1384
69. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y (1990) Interleukin-1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166:324-329
70. Xionan Xin, Yiqiang Cai, Kozo Matsumoto, Takashi Agui (1995) Endothelin-induced interleukin-6 production by rat aortic endothelial cells. Endocrinology 136:132-137
71. Shichiri M, Kato H, Marumo F, Hirata Y (1997) Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 30:1198-1203
72. Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ (1997) Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 328:733-737
73. Koide M, Kawahara Y, Tsuda T, Ishida Y, Shii K, Yokoyama M (1992) Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J Hypertens 10:1173-1182
74. Hetts SW (1998) To die or not to die: an overview of apoptosis and its role in disease. JAMA 279:300-307
75. Pullman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 4:222-227
76. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law P, Hebbel R (1999) VEGF prevents apoptosis of human mivrovascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247:495-504
77. Hebert MJ, Gullans SR, Mackenzie HS, Brady HR (1998) Apoptosis of endothelial cells is associated with paracrine production of adhesion molecules: evidence for an interleukin-1-beta-dependent paracrine loop. Am J Pathol 152:523-532
78. Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M, Pober JS (1997) Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest 77:257-267
79. Kondo S, Kondo Y, Yin D, Barnett GH, Kaakaji R, Peterson JW, Morimura T, Kubo H, Takeuchi J, Barna BP (1996) Involvement of interleukin-1 beta-converting enzyme in apoptosis of bFGF-deprived murine aortic endothelial cells. FASEB J 10:1192-1197
80. Solovey A, Gui L, Ramakrishnan S, Steinberg MH, Hebbel RP (1999). Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 93:3824-3830
81. Thomas AN, Pattison C, Serjeant GR (1982) Causes of death in sickle-cell disease in Jamaica. BMJ 285:633-639
82. Rautonen N, Martin NL, Rautonen J, Rooks Y, Mentzer WC, Wara D (1992) Low number of antibody producing cells in patients with sickle cell anemia. Immunol Lett 34:207-211
83. Croizat H (1994) Circulating cytokines in sickle cell patients during steady state. Br J Hematol 87:592-597
84. Taylor SC, Shacks SJ, Mitchell RA, Banks A (1995) Serum interleukin-6 levels in the steady state of sickle cell disease. J Interferon Cytokine Res 15:1061-1064
85. Taylor SC, Shacks SJ, Ou Z, Wiley P (1997) Type 2 cytokine serum levels in healthy sickle cell disease patients. J Natl Med Assoc 89:753-757
86. Taylor S, Shacks S, Ou Z, Colaco V (1997) In vitro suppression of the normal mitogenic T lymphocyte response by steady state sickle cell disease sera. Immunol Invest 26:561-568
87. Taylor SC, Shacks SJ, Villicana SM, Olivares J, Dinkins GA (1990) Interferon production in sickle cell disease. Lymphokine Res 9:415-423
88. Taylor SC, Shacks SJ, Mitchell RA (1996) In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J 15:340-344
89. Kaaba SA, al-Harbi SA (1993) Reduced levels of CD2+ cells and T-cell subsets in patients with sickle cell anaemia. Immunol Lett 37:77-81
90. Croizat H, Nagel R (1999). Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. Am J Hematol 60:105-115
91. Platt OS, Rosenstock W, Espeland MA (1984) Influence of sickle hemoglinopathies on growth and development. N Engl J Med 311:7-12
92. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM (1996) Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153:633-637
93. Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF (1990) Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 323:366-372
94. Bourantas K, Makrydimas G, Georgiou S, Tsiara St, Lolis D (1996) Preliminary results with administration of recombinant human erythropoietin in sickle cell/β thalassemia patients during pregnancy. Eur J Hematol 96:326-328